Evaluation of Plasmatic Levels of Busulfan in Patients Undergoing Hematopoietic Stem Cell Transplantation
Condition(s):Acute Leukemia; Chronic Leukemia; Lymphoproliferative Disease; Myeloproliferative Disease; ImmunodeficiencyLast Updated:December 3, 2014Unknown status